Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma

Authors: Thomas Kaley, Katherine S. Panageas, Ingo K. Mellinghoff, Craig Nolan, Igor T. Gavrilovic, Lisa M. DeAngelis, Lauren E. Abrey, Eric C. Holland, Andrew B. Lassman - Journal of Neuro-Oncology 2019 cited by 62